Search

everythinglearnresearchcommunity

for

Search:↓

People with chronic hair loss often have lower Vitamin B12 levels.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hirsutism causes significant psychological distress in women.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

PCOS increases sexual pain distress in infertile women.

The case shows the difficulty in diagnosing certain conditions when standard tests are negative.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Most women with PCOS have insulin resistance, especially those with phenotype B.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

Iron and zinc deficiencies may be treated to help female hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Finasteride reduces hair growth and is safe for women with excessive hair.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Melatonin given to pregnant rabbits improved their babies' fur quality.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.